1. Home
  2. ACET vs SELX Comparison

ACET vs SELX Comparison

Compare ACET & SELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACET
  • SELX
  • Stock Information
  • Founded
  • ACET 1947
  • SELX 2021
  • Country
  • ACET United States
  • SELX Taiwan
  • Employees
  • ACET N/A
  • SELX N/A
  • Industry
  • ACET Biotechnology: Pharmaceutical Preparations
  • SELX
  • Sector
  • ACET Health Care
  • SELX
  • Exchange
  • ACET Nasdaq
  • SELX Nasdaq
  • Market Cap
  • ACET 64.9M
  • SELX 61.7M
  • IPO Year
  • ACET N/A
  • SELX N/A
  • Fundamental
  • Price
  • ACET $0.67
  • SELX $1.35
  • Analyst Decision
  • ACET Buy
  • SELX
  • Analyst Count
  • ACET 6
  • SELX 0
  • Target Price
  • ACET $6.00
  • SELX N/A
  • AVG Volume (30 Days)
  • ACET 412.2K
  • SELX 3.5K
  • Earning Date
  • ACET 08-12-2025
  • SELX 01-01-0001
  • Dividend Yield
  • ACET N/A
  • SELX N/A
  • EPS Growth
  • ACET N/A
  • SELX N/A
  • EPS
  • ACET N/A
  • SELX N/A
  • Revenue
  • ACET N/A
  • SELX $1,040,571.00
  • Revenue This Year
  • ACET N/A
  • SELX N/A
  • Revenue Next Year
  • ACET N/A
  • SELX N/A
  • P/E Ratio
  • ACET N/A
  • SELX N/A
  • Revenue Growth
  • ACET N/A
  • SELX N/A
  • 52 Week Low
  • ACET $0.45
  • SELX $1.00
  • 52 Week High
  • ACET $1.70
  • SELX $2.07
  • Technical
  • Relative Strength Index (RSI)
  • ACET 43.24
  • SELX 38.61
  • Support Level
  • ACET $0.72
  • SELX $1.22
  • Resistance Level
  • ACET $0.84
  • SELX $1.47
  • Average True Range (ATR)
  • ACET 0.06
  • SELX 0.09
  • MACD
  • ACET -0.02
  • SELX -0.01
  • Stochastic Oscillator
  • ACET 0.00
  • SELX 11.32

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

Share on Social Networks: